The CSL (ASX:CSL) share price has gained 14% in the last 6 months

Here's what's been driving the CSL share price lately.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The CSL Limited (ASX: CSL) share price has gained 14.36% over the last 6 months, despite limited news having been released by the company.

However, the period has been a busy one for CSL, as detailed in its financial year 2021 results which dropped last week.

Right now, the CSL share price is $306.91, having gained 0.26% today.

Let's take a closer look at what CSL has been up to over the past 6 months.

The 6 months just gone for CSL

The CSL share price is currently a whopping 14% higher than it was exactly 6 months ago, despite the company having been relatively quiet. Indeed, the most exciting news from CSL was also its most recent.

CSL released its full-year report to the market on Wednesday last week. Over the financial year 2021, CSL's revenue increased 9.6% and its profit after tax boosted 10% higher.

Additionally, the company increased its final dividend by 10% to US$2.22 per share.

While the CSL share price initially fell 1.4% on its FY21 results, it has gained since 4.5%.

The only other time the ASX heard price-sensitive news from CSL during the last 6 months was in May when the company announced it was to acquire the rights for etranacogene dezaparvovec (AMT-061), a late-stage haemophilia B treatment.

The deal saw CSL pay Uniqure NV US$450 million for the rights. CSL also agreed to provide milestone royalty payments to Uniqure.

Additionally, as The Motley Fool Australia recently reported, CSL's gains could have been helped along by its candidacy in potentially producing mRNA vaccines in Australia, or the Australian dollar's strength against that of the US.

CSL share price snapshot

The last 6 months have seen the CSL share price perform a strong upturn.

Right now, it is 8.3% higher than it was at the start of 2021. It is also 3.8% higher than it was this time last year.

Motley Fool contributor Brooke Cooper has no position in any of the stocks mentioned.

The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of and has recommended CSL Ltd. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

CSL share price leaping higher amid $1.9 billion funding news

ASX 200 investors are bidding up the CSL share price on Wednesday.

Read more »

Two happy scientists analysing test results.
Healthcare Shares

Mesoblast share price rockets 36% on breaking FDA news

ASX investors are sending the Mesoblast share price soaring following promising FDA news.

Read more »

a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
Healthcare Shares

Guess which ASX 200 healthcare share is jumping 7% on a guidance update

This healthcare share is performing better than expected in FY 2024.

Read more »

a biomedical researcher sits at his desk with his hand on his chin, thinking and giving a small smile with a microscope next to him and an array of test tubes and beackers behind him on shelves in a well-lit bright office.
Earnings Results

Chemist Warehouse merger target Sigma reports 149% FY24 profit jump

This could be the last set of results from Sigma as we know it if its merger is approved.

Read more »

Cropped shot of an attractive young female scientist working on her computer in the laboratory.
Healthcare Shares

1 ASX healthcare stock that looks severely undervalued

I think this stock looks too cheap to miss.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Own Medibank shares? Here's why it's a rewarding day for you

Shareholders are getting a healthy boost today.

Read more »

Health professional looking at a laptop.
Healthcare Shares

Are CSL shares a must-buy in March?

Let's see what analysts are saying about this high-quality company.

Read more »

A woman jumps for joy with a rocket drawn on the wall behind her.
Healthcare Shares

This ASX healthcare stock is up 72% on FDA news and 'historic moment'

Huge gains are been recorded by this stock on Tuesday. But why?

Read more »